Valente PMS - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment.

Valente PMS, da Silva PN, da Silva LE, Martins WA, de Castilho SR. Valente PMS, et al. Front Pharmacol. 2023 Sep 18;14:1099545. doi: 10.3389/fphar.2023.1099545. eCollection 2023. Front Pharmacol. 2023. PMID: 37795021 Free PMC article.

Familial breast cancer, pregnancy and cardiotoxicity associated with the use of doxorubicin and reaction with trastuzumab.

Valente PMS, Gomes MCB, Martins WA, Castilho SR. Valente PMS, et al. J Oncol Pharm Pract. 2022 Dec;28(8):1893-1897. doi: 10.1177/10781552221080081. Epub 2022 Mar 23. J Oncol Pharm Pract. 2022. PMID: 35321591

Monoclonal-induced cardiotoxicity in patients with non-Hodgkin's lymphoma and breast cancer: A retrospective study in an oncology clinic.

Silva PND, Valente PMS, Castilho SR. Silva PND, et al. Among authors: valente pms. J Oncol Pharm Pract. 2023 Jul;29(5):1125-1134. doi: 10.1177/10781552221098426. Epub 2022 May 11. J Oncol Pharm Pract. 2023. PMID: 35542978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters